InvestorsHub Logo
Followers 7
Posts 189
Boards Moderated 0
Alias Born 04/10/2015

Re: Musical Shares post# 92324

Sunday, 09/26/2021 10:00:07 PM

Sunday, September 26, 2021 10:00:07 PM

Post# of 118421
What I meant was, small biotechs accumulate a lot of debt so it's not wrong to say they're not doing well financially, but could still be bought out. You can have a "losing" biotech and a "promising" biotech - both can have enormous debt.

In reference to small biotechs not being bought out, I'm not sure what you mean by "never seen it happen." I can think of many examples, not least Moderna. Moderna was never bought out. They had numerous partnerships over the years, including AstraZeneca, and they also had very good financial support through some partners. But in no way was Moderna "bought out." They were never for sale.

"Big Pharma" will buy anything they think they can profit from, just like any other big company.

In any case, RGBP is a one man show right now and buyout is probably its best hope. I hope it happens - I own a bunch of shares.